Stay updated on Empagliflozin in Heart Failure Function: Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin in Heart Failure Function: Clinical Trial page.

Latest updates to the Empagliflozin in Heart Failure Function: Clinical Trial page
- Check4 days agoChange DetectedAdded a government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check11 days agoChange DetectedAdded a glossary toggle and color-coding explanations (green/red highlights) to the study history page, and updated revision labels to v3.4.0 while removing the older No FEAR Act data reference (v3.3.4).SummaryDifference0.6%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.3.4 appears, replacing the previous Revision: v3.3.3. This is a minor technical update to the page header and does not change the trial data, status, or listed details.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.3.3 was added to the page history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. These are minor site maintenance updates that do not affect study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page history now shows Revision: v3.3.2 as the latest version and no longer lists Revision: v3.3.1. This update is limited to the revision history UI and does not affect any study data or page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange DetectedA new history revision v3.3.1 was added and an older revision v3.2.0 was removed from the Record History page.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin in Heart Failure Function: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin in Heart Failure Function: Clinical Trial page.